Medical Xpress February 17, 2025
Artificial intelligence (AI) can rapidly screen patients for clinical trial enrollment, according to a study published in JAMA and led by Mass General Brigham researchers. Their novel AI-assisted patient screening tool significantly improved the speed of determining eligibility and enrollment in a heart failure clinical trial compared to manual screening.
These findings suggest that using AI can be cheaper than conventional methods and speed up the research process, which could mean patients get earlier access to proven, effective treatments.
“Seeing this AI capability accelerate screening and trial enrollment this substantially in the context of a real-world randomized prospective trial is exciting,” said co-senior author Samuel (Sandy) Aronson, ALM, MA, executive director of IT and AI Solutions for Mass General Brigham...
Today's Sponsors
Today's Sponsor